Sagimet Biosciences Files 8-K

Ticker: SGMT · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1400118

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

Sagimet Biosciences filed an 8-K on June 4, 2025, likely containing important company updates.

AI Summary

On June 4, 2025, Sagimet Biosciences Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates Sagimet Biosciences is providing updates or disclosures to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial or operational details that would indicate a high-risk event.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on June 4, 2025.

In which state was Sagimet Biosciences Inc. incorporated?

Sagimet Biosciences Inc. was incorporated in Delaware.

What is the principal executive office address for Sagimet Biosciences Inc.?

The principal executive office address is 155 Bovet Road, Suite 303, San Mateo, California 94402.

What was the former name of Sagimet Biosciences Inc.?

The former name of Sagimet Biosciences Inc. was 3-V Biosciences, Inc.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Sagimet Biosciences Inc. (SGMT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing